Cerebrovascular Diseases

Stroke Notes

Free Access

Assessment of Pial Branches Using 7-Tesla MRI in Cerebral Arterial Disease

Song H.-S.a · Kang C.-K.d · Kim J.S.b · Park C.-A.d · Kim Y.-B.d · Lee D.H.c · Kang D.-W.b · Kwon S.U.b · Cho Z.-H.d

Author affiliations

aDepartment of Neurology, College of Medicine, Kyung Hee University, and Departments of bNeurology and cRadiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, and dNeuroscience Research Institute, Gachon University of Medicine and Science, Incheon, Korea

Corresponding Author

Jong S. Kim, MD, PhD

Department of Neurology, University of Ulsan College of Medicine Asan Medical Center, 388-1 Pungnap 2-dong

Songpa-gu, Seoul 138-736 (Korea)

Tel. +82 2 3010 3442, Fax +82 2 474 4691

E-Mail jongskim@amc.seoul.kr

or Zang-Hee Cho, PhD, E-Mail zcho@gachon.ac.kr

Related Articles for ""

Cerebrovasc Dis 2010;29:410–411

First-Page Preview
Abstract of Stroke Notes



Related Articles:


Article / Publication Details

Published online: February 26, 2010
Issue release date: March 2010

Number of Print Pages: 2
Number of Figures: 1
Number of Tables: 0

ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)

For additional information: https://www.karger.com/CED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP